[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Benign Prostatic Hyperplasia (BPH) Drugs Market Professional Survey Report 2018

March 2018 | 114 pages | ID: G3C85C4F8FEEN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Benign Prostatic Hyperplasia (BPH) Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Astellas Pharma
  • Eli Lilly
  • GlaxoSmithKline
  • Sanofi
  • ADC Therapeutics
  • Bayer HealthCare
  • Bristol-Myers Squibb
  • Valeant Pharmaceuticals
  • Endo Pharmaceuticals
  • Foresee Pharmaceuticals
  • Madrigal Pharmaceuticals
  • Merck
  • Novartis
  • Spectrum Pharmaceuticals
  • Takeda Pharmaceuticals
  • Teva
  • Advaxis
  • ANI Pharmaceuticals
  • BHR Pharma
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Alpha-blocker
  • Phosphodiesterase Type-5 Inhibitors
  • 5-alpha-Reductase Inhibitors
By Application, the market can be split into
  • Hospitals
  • Clinics
  • Others
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Benign Prostatic Hyperplasia (BPH) Drugs Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS

1.1 Definition and Specifications of Benign Prostatic Hyperplasia (BPH) Drugs
  1.1.1 Definition of Benign Prostatic Hyperplasia (BPH) Drugs
  1.1.2 Specifications of Benign Prostatic Hyperplasia (BPH) Drugs
1.2 Classification of Benign Prostatic Hyperplasia (BPH) Drugs
  1.2.1 Alpha-blocker
  1.2.2 Phosphodiesterase Type-5 Inhibitors
  1.2.3 5-alpha-Reductase Inhibitors
1.3 Applications of Benign Prostatic Hyperplasia (BPH) Drugs
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
2.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
2.4 Industry Chain Structure of Benign Prostatic Hyperplasia (BPH) Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS

3.1 Capacity and Commercial Production Date of Global Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2017

4 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity and Growth Rate Analysis
  4.2.2 2017 Benign Prostatic Hyperplasia (BPH) Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate Analysis
  4.3.2 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Price
  4.4.2 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Analysis (Company Segment)

5 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis
  5.1.1 North America Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
  5.1.2 North America 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Analysis
  5.1.4 North America 2017 Benign Prostatic Hyperplasia (BPH) Drugs Market Share Analysis
5.2 China Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis
  5.2.1 China Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
  5.2.2 China 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Analysis
  5.2.4 China 2017 Benign Prostatic Hyperplasia (BPH) Drugs Market Share Analysis
5.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis
  5.3.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
  5.3.2 Europe 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Analysis
  5.3.4 Europe 2017 Benign Prostatic Hyperplasia (BPH) Drugs Market Share Analysis
5.4 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis
  5.4.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
  5.4.2 Southeast Asia 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2017 Benign Prostatic Hyperplasia (BPH) Drugs Market Share Analysis
5.5 Japan Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis
  5.5.1 Japan Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
  5.5.2 Japan 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Analysis
  5.5.4 Japan 2017 Benign Prostatic Hyperplasia (BPH) Drugs Market Share Analysis
5.6 India Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis
  5.6.1 India Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
  5.6.2 India 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Analysis
  5.6.4 India 2017 Benign Prostatic Hyperplasia (BPH) Drugs Market Share Analysis

6 GLOBAL 2013-2018E BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales by Type
6.2 Different Types of Benign Prostatic Hyperplasia (BPH) Drugs Product Interview Price Analysis
6.3 Different Types of Benign Prostatic Hyperplasia (BPH) Drugs Product Driving Factors Analysis
  6.3.1 Alpha-blocker of Benign Prostatic Hyperplasia (BPH) Drugs Growth Driving Factor Analysis
  6.3.2 Phosphodiesterase Type-5 Inhibitors of Benign Prostatic Hyperplasia (BPH) Drugs Growth Driving Factor Analysis
  6.3.3 5-alpha-Reductase Inhibitors of Benign Prostatic Hyperplasia (BPH) Drugs Growth Driving Factor Analysis

7 GLOBAL 2013-2018E BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Consumption by Application
7.2 Different Application of Benign Prostatic Hyperplasia (BPH) Drugs Product Interview Price Analysis
7.3 Different Application of Benign Prostatic Hyperplasia (BPH) Drugs Product Driving Factors Analysis
  7.3.1 Hospitals of Benign Prostatic Hyperplasia (BPH) Drugs Growth Driving Factor Analysis
  7.3.2 Clinics of Benign Prostatic Hyperplasia (BPH) Drugs Growth Driving Factor Analysis
  7.3.3 Others of Benign Prostatic Hyperplasia (BPH) Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS

8.1 Astellas Pharma
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Astellas Pharma 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Astellas Pharma 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.2 Eli Lilly
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Eli Lilly 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Eli Lilly 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.3 GlaxoSmithKline
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 GlaxoSmithKline 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 GlaxoSmithKline 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.4 Sanofi
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Sanofi 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Sanofi 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.5 ADC Therapeutics
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 ADC Therapeutics 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 ADC Therapeutics 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.6 Bayer HealthCare
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Bayer HealthCare 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Bayer HealthCare 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.7 Bristol-Myers Squibb
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Bristol-Myers Squibb 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Bristol-Myers Squibb 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.8 Valeant Pharmaceuticals
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Valeant Pharmaceuticals 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Valeant Pharmaceuticals 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.9 Endo Pharmaceuticals
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Endo Pharmaceuticals 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Endo Pharmaceuticals 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.10 Foresee Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Foresee Pharmaceuticals 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Foresee Pharmaceuticals 2017 Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution Analysis
8.11 Madrigal Pharmaceuticals
8.12 Merck
8.13 Novartis
8.14 Spectrum Pharmaceuticals
8.15 Takeda Pharmaceuticals
8.16 Teva
8.17 Advaxis
8.18 ANI Pharmaceuticals
8.19 BHR Pharma

9 DEVELOPMENT TREND OF ANALYSIS OF BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET

9.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Trend Analysis
  9.1.1 Global 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Sales Price Forecast
9.2 Benign Prostatic Hyperplasia (BPH) Drugs Regional Market Trend
  9.2.1 North America 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Forecast
  9.2.2 China 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Forecast
  9.2.3 Europe 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Forecast
  9.2.4 Southeast Asia 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Forecast
  9.2.5 Japan 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Forecast
  9.2.6 India 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Forecast
9.3 Benign Prostatic Hyperplasia (BPH) Drugs Market Trend (Product Type)
9.4 Benign Prostatic Hyperplasia (BPH) Drugs Market Trend (Application)

10 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKETING TYPE ANALYSIS

10.1 Benign Prostatic Hyperplasia (BPH) Drugs Regional Marketing Type Analysis
10.2 Benign Prostatic Hyperplasia (BPH) Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Benign Prostatic Hyperplasia (BPH) Drugs by Region
10.4 Benign Prostatic Hyperplasia (BPH) Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Benign Prostatic Hyperplasia (BPH) Drugs
Table Product Specifications of Benign Prostatic Hyperplasia (BPH) Drugs
Table Classification of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Global Production Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Type in 2017
Figure Alpha-blocker Picture
Table Major Manufacturers of Alpha-blocker
Figure Phosphodiesterase Type-5 Inhibitors Picture
Table Major Manufacturers of Phosphodiesterase Type-5 Inhibitors
Figure 5-alpha-Reductase Inhibitors Picture
Table Major Manufacturers of 5-alpha-Reductase Inhibitors
Table Applications of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Global Consumption Volume Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Application in 2017
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Regions
Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) (2013-2025)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) (2013-2025)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) (2013-2025)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) (2013-2025)
Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) (2013-2025)
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) (2013-2025)
Table Benign Prostatic Hyperplasia (BPH) Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia (BPH) Drugs in 2017
Figure Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Industry Chain Structure of Benign Prostatic Hyperplasia (BPH) Drugs
Table Capacity and Commercial Production Date of Global Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Benign Prostatic Hyperplasia (BPH) Drugs Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Benign Prostatic Hyperplasia (BPH) Drugs 2013-2018E
Figure Global 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Value) and Growth Rate
Table 2013-2018E Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity and Growth Rate
Table 2017 Global Benign Prostatic Hyperplasia (BPH) Drugs Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (K Units) and Growth Rate
Table 2017 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales (K Units) List (Company Segment)
Table 2013-2018E Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Unit)
Table 2017 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Benign Prostatic Hyperplasia (BPH) Drugs 2013-2018E
Figure North America 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Unit)
Figure North America 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Benign Prostatic Hyperplasia (BPH) Drugs 2013-2018E
Figure China 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Unit)
Figure China 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Benign Prostatic Hyperplasia (BPH) Drugs 2013-2018E
Figure Europe 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Unit)
Figure Europe 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Benign Prostatic Hyperplasia (BPH) Drugs 2013-2018E
Figure Southeast Asia 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Benign Prostatic Hyperplasia (BPH) Drugs 2013-2018E
Figure Japan 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Unit)
Figure Japan 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Benign Prostatic Hyperplasia (BPH) Drugs 2013-2018E
Figure India 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Unit)
Figure India 2017 Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share
Table Global 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales (K Units) by Type
Table Different Types Benign Prostatic Hyperplasia (BPH) Drugs Product Interview Price
Table Global 2013-2018E Benign Prostatic Hyperplasia (BPH) Drugs Sales (K Units) by Application
Table Different Application Benign Prostatic Hyperplasia (BPH) Drugs Product Interview Price
Table Astellas Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2017 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2017 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2015 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2017 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table ADC Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2017 ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table Bayer HealthCare Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bayer HealthCare Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bayer HealthCare Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table Valeant Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2017 Valeant Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Valeant Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table Endo Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2017 Endo Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Endo Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table Foresee Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2017 Foresee Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Foresee Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Business Region Distribution
Table Madrigal Pharmaceuticals Information List
Table Merck Information List
Table Novartis Information List
Table Spectrum Pharmaceuticals Information List
Table Takeda Pharmaceuticals Information List
Table Teva Information List
Table Advaxis Information List
Table ANI Pharmaceuticals Information List
Table BHR Pharma Information List
Figure Global 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Benign Prostatic Hyperplasia (BPH) Drugs by Type 2018-2025
Table Global Consumption Volume (K Units) of Benign Prostatic Hyperplasia (BPH) Drugs by Application 2018-2025
Table Traders or Distributors with Contact Information of Benign Prostatic Hyperplasia (BPH) Drugs by Region

More Publications

Need Help?

Ask a Question

Market Reports

All Categories